🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

4 Capsule(s) Serving Size
15 Servings
Amino acid/Protein Product Type
20% Evidence Coverage

Supplement Facts — Evidence Check

Calories
12 Calorie(s)
Protein
3 Gram(s) (6% DV)
📊 Market median: 500.0mg (180 products) 📚 5 studies (Tier A: 0, B: 1)
This product: 3000mg

Other Ingredients

Hypromellose Water, Purified Magnesium Stearate

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (98% of products) Structure/Function (78% of products) Nutrient (56% of products)

Target Groups

Adult (18 - 50 Years) Kosher Gluten Free Sugar Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take four capsules once daily or as directed by a healthcare practitioner.

⚠️ Warnings & Precautions

Caution: For adults only.

Consult physician if pregnant/nursing, taking medication, or have a medical condition.

Keep out of reach of children.

Contains: Milk, egg

🧪 Formulation Notes

Bluebonnet's Amino Acid Vegetable Capsules are formulated with amino acids and dipeptide bonded amino acids derived entirely from whey lactalbumin and egg white albumin proteins to help support muscle growth, strength, and repair.

Free of fish, crustacean shellfish, tree nut, peanuts, wheat, soybeans and sesame. Also free of corn, gluten, barley, rice, sodium and sugar.

Bluebonnet KOF-K certification #K-0000700

Made with Non GMO ingredients

Muscle growth, strength & repair

Gluten free

KOF-K (Kosher) Dairy

Additional Information

Made with Non GMO ingredients KOF-K (Kosher) Dairy

Product Details

UPC / SKU 7 43715 00010 0
DSLD Entry Date 2024-06-20
Product Type Amino acid/Protein
Form Capsule
Brand Bluebonnet
DSLD ID 314984
Data Updated 2026-04-11

Research Evidence

50 Research Sources
47 Avg Quality Score
28 Rct
13 Clinical Trial
5 Guideline
4 Systematic Review
A Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
Guideline International journal of molecular sciences 2025
B Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
Guideline Internal medicine journal 2025
B Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
Systematic Review The Cochrane database of systematic reviews 2020
B [Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)].
Guideline Zhonghua zhong liu za zhi [Chinese journal of oncology] 2025
B [Chinese expert consensus on epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer (2025 edition)].
Guideline Zhonghua yi xue za zhi 2025
B Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
Guideline Journal of inherited metabolic disease 2025
B Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
Rct Cognitive, affective & behavioral neuroscience 2020
B Effect of Amino Acid Supplementation on Iron Regulation after Endurance Exercise
Rct Nutrients 2023
C Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression
Systematic Review Sports medicine - open 2024
C The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review
Systematic Review Plant foods for human nutrition (Dordrecht, Netherlands) 2020
View all evidence for Tyrosine →

Compare Similar Products

View all Tyrosine products →